Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Authors not listed
Florida Atlantic University · 2007
Abstract
The purpose of the study is to determine whether memantine delays the progression of driving impairment in patients with mild Alzheimer's Disease (AD).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2007). Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease. <em>Florida Atlantic University</em>. https://clinicaltrials.gov/study/NCT00476008
Vancouver
Anonymous. Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease. Florida Atlantic University. 2007.
BibTeX
@misc{anon2007Delayi,
title = {Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease},
author = {Anonymous},
journal = {Florida Atlantic University},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
US Department of Veterans Affairs 2007
Open access · US-GOV
CSP #546 - A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease (TEAM-AD)
Eli Lilly and Company 2016
Open access · US-GOV
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
NVP Healthcare 2026
Open access · US-GOV